{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:37:28Z","timestamp":1774460248222,"version":"3.50.1"},"reference-count":29,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1136\/bjophthalmol-2015-306828","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T03:23:42Z","timestamp":1446607422000},"page":"929-932","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole"],"prefix":"10.1136","volume":"100","author":[{"given":"Jennifer","family":"Rose-Nussbaumer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N Venkatesh","family":"Prajna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiruvengada","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeena","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revathi","family":"Rajaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthiah","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine E","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran S","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn J","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis C","family":"Porco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha R","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy D","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M","family":"Lietman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2015-306828-1","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1167\/iovs.10-5627","article-title":"Use of patient-reported outcomes in medical product development: a report from the 2009 NEI\/FDA Clinical Trial Endpoints Symposium","volume":"51","author":"Varma","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306828-2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/bjo.2004.050732","article-title":"The development of the Indian vision function questionnaire: field testing and psychometric evaluation","volume":"89","author":"Gupta","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/bjo.2004.047217","article-title":"The development of the Indian vision function questionnaire: questionnaire content","volume":"89","author":"Murthy","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-5","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1167\/iovs.11-7388","article-title":"The impact of the severity of vision loss on vision-related quality of life in India: an evaluation of the IND-VFQ-33","volume":"52","author":"Finger","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306828-6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00003226-200208000-00004","article-title":"The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India","volume":"21","author":"Gopinathan","year":"2002","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-306828-7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ophtha.2005.10.063","article-title":"Risk factors for treatment outcome in fungal keratitis","volume":"113","author":"Lalitha","year":"2006","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306828-8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bjo.2009.169607","article-title":"Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature","volume":"95","author":"Shah","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jamaophthalmol.2013.1497","article-title":"The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole","volume":"131","author":"Prajna","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-10","doi-asserted-by":"crossref","unstructured":"J Rose-Nussbaumer NP , Krishnan T , Mascarenhas J , et al. Visual function 453 questionnaire outcomes in the mycotic ulcer treatment trial: a randomized trial 454 comparing natamycin to voriconazole. JAMA Ophthal 2015;133:6426.","DOI":"10.1001\/jamaophthalmol.2015.0319"},{"key":"key-10.1136\/bjophthalmol-2015-306828-11","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"key-10.1136\/bjophthalmol-2015-306828-12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/OPX.0000000000000003","article-title":"National Eye Institute Visual Function Questionnaire: usefulness in glaucoma","volume":"90","author":"Nassiri","year":"2013","journal-title":"Optom Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306828-13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archopht.125.11.1460","article-title":"Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial","volume":"125","author":"Chang","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-14","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1167\/iovs.04-0830","article-title":"Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey","volume":"46","author":"Nirmalan","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306828-15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/bjo.86.9.993","article-title":"Correlation between visual function and visual ability in patients with uveitis","volume":"86","author":"Gardiner","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1167\/iovs.11-8259","article-title":"Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial","volume":"53","author":"Frick","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306828-17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/09286580701502970","article-title":"Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19","volume":"14","author":"Submacular Surgery Trials Research G","year":"2007","journal-title":"Ophthalmic Epidemiol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/OPX.0000000000000156","article-title":"Vision-related quality of life in patients with infectious keratitis","volume":"91","author":"Li","year":"2014","journal-title":"Optom Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306828-19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2007.135913","article-title":"Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire","volume":"94","author":"Awdeh","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archopht.121.9.1297","article-title":"Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire","volume":"121","author":"Deramo","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.2006.105528","article-title":"Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis","volume":"91","author":"Murphy","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ajo.2011.06.028","article-title":"Depression and visual functioning in patients with ocular inflammatory disease","volume":"153","author":"Qian","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1477-7525-2-44","article-title":"Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sj\u00f6gren's syndrome-related dry eye","volume":"2","author":"Vitale","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"key-10.1136\/bjophthalmol-2015-306828-24","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1167\/iovs.10-5645","article-title":"Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration","volume":"52","author":"Orr","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306828-25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00417-011-1646-4","article-title":"The impact of the severity of vision loss on vision-specific functioning in a German outpatient population\u2014an observational study","volume":"249","author":"Finger","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ophtha.2006.11.012","article-title":"Relationship between visual impairment and eye diseases and visual function in Andhra Pradesh","volume":"114","author":"Nutheti","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306828-27","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1167\/iovs.06-0020","article-title":"Impact of impaired vision and eye disease on quality of life in Andhra Pradesh","volume":"47","author":"Nutheti","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306828-28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(99)80231-1","article-title":"The Madurai Intraocular Lens Study. III: Visual functioning and quality of life outcomes","volume":"125","author":"Fletcher","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306828-29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0002-9394(75)90730-8","article-title":"Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture","volume":"79","author":"Jones","year":"1975","journal-title":"Am J Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2015-306828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T03:43:01Z","timestamp":1653450181000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2015-306828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,6,21]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1136\/bjophthalmol-2015-306828"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306828","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]}}}